Alec P. Pankow
Alec is a Ph.D. Student in the Rosenberg lab. He earned a B.S. in biochemistry from the University of Puget Sound in Tacoma, Washington before going on to work as a molecular biology research technician at the University of Washington in Seattle and a bioinformatician at Karolinska Institute in Stockholm, Sweden. At UW, Alec studied HIV pathogenesis and latency in Dr. Jim Mullins’ molecular retrovirology laboratory. While there, he helped develop a bench protocol and computational pipeline which used PacBio long-read sequencing for accurate assessment of viral quasispecies. After joining Dr. Benjamin Murrell’s group at Karolinska in the Spring of 2020, Alec leveraged camelid single-domain antibody (or nanobody) repertoire sequencing to predict neutralizing antibody candidates against SARS-CoV-2 spike protein. As a graduate student in the Rosenberg lab, he is now focused on technology development for high-content CRISPR screens and model culture systems for studying respiratory virus infection.
Outside the lab, Alec enjoys exploring New York City on foot and scrolling though bike ads online.


Alec P. Pankow
Alec is a Ph.D. Student in the Rosenberg lab. He earned a B.S. in biochemistry from the University of Puget Sound in Tacoma, Washington before going on to work as a molecular biology research technician at the University of Washington in Seattle and a bioinformatician at Karolinska Institute in Stockholm, Sweden. At UW, Alec studied HIV pathogenesis and latency in Dr. Jim Mullins’ molecular retrovirology laboratory. While there, he helped develop a bench protocol and computational pipeline which used PacBio long-read sequencing for accurate assessment of viral quasispecies. After joining Dr. Benjamin Murrell’s group at Karolinska in the Spring of 2020, Alec leveraged camelid single-domain antibody (or nanobody) repertoire sequencing to predict neutralizing antibody candidates against SARS-CoV-2 spike protein. As a graduate student in the Rosenberg lab, he is now focused on technology development for high-content CRISPR screens and model culture systems for studying respiratory virus infection.
Outside the lab, Alec enjoys exploring New York City on foot and scrolling though bike ads online.